Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mary E. Enama
Phase I Clinical Evaluation of Seasonal Influenza Hemagglutinin (HA) DNA Vaccine Prime Followed by Trivalent Influenza Inactivated Vaccine (IIV3) Boost
Contemporary Clinical Trials
Medicine
Pharmacology
Related publications
Immunogenicity, Safety and Consistency of New Trivalent Inactivated Influenza Vaccine
Vaccine
Molecular Medicine
Public Health
Veterinary
Microbiology
Environmental
Immunology
Infectious Diseases
Occupational Health
538 Severity of Breakthrough Influenza Illness Among Children and Adults Receiving Live Attenuated Influenza Vaccine and Trivalent Inactivated Influenza Vaccine
Pediatric Research
Child Health
Pediatrics
Perinatology
Clinical Reactivity and Immunogenicity of Hemagglutinin Influenza Vaccine
Archives of Virology
Medicine
Virology
Cumulative Clinical Experience With MF59-Adjuvanted Trivalent Seasonal Influenza Vaccine in Young Children
International Journal of Infectious Diseases
Medicine
Infectious Diseases
Microbiology
Hemagglutinin Quantitative ELISA-based Potency Assay for Trivalent Seasonal Influenza Vaccine Using Group-Specific Universal Monoclonal Antibodies
Scientific Reports
Multidisciplinary
Trivalent Inactivated Influenza Vaccine Is Not Associated With Sickle Cell Crises in Children
Pediatrics
Child Health
Pediatrics
Perinatology
Quadrivalent Versus Trivalent Influenza Vaccine: Clinical Outcomes in Two Influenza Seasons, Historical Cohort Study
Clinical Microbiology and Infection
Medicine
Infectious Diseases
Microbiology
Safety of Trivalent Inactivated Influenza Vaccine in Children Aged 24 to 59 Months in the Vaccine Safety Datalink
Archives of Pediatrics & Adolescent Medicine
Discordance Between Antibody and T Cell Responses in Recipients of Trivalent Inactivated Influenza Vaccine
Vaccine
Molecular Medicine
Public Health
Veterinary
Microbiology
Environmental
Immunology
Infectious Diseases
Occupational Health
